Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 1012, pseudogene (RNU6-1012P) is a non-functional, processed pseudogene originating from the U6 small nuclear RNA gene. U6 snRNA is normally a catalytic RNA component of the spliceosome, essential for pre-mRNA splicing in eukaryotes[6]. Pseudogenes such as RNU6-1012P arise from reverse transcription and genomic integration of snRNA transcripts, often mediated by retrotransposons like LINE-1 (L1), and do not contribute to splicing or other cellular functions[2]. RNU6-1012P serves as a genomic marker of historical retrotransposon activity but does not encode any product or participate in conventional biological processes[2]. RNU6-1012P is a processed pseudogene, not a functional gene or therapeutic target. It is not involved in disease, biology, or drug action, and serves only as a marker of retrotransposition dynamics in genomic studies[2][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 1012, pseudogene (RNU6-1012P).